Hedge funds sour on HCA — 5 market insights

According to recent filings, institutional investors are reducing their positions in Nashville, Tenn.-based HCA Healthcare in droves, the Frisco Fastball reports.

Here's what you should know:

1. Since the second quarter of fiscal year 2017, 249 investors have sold or reduced their equity in HCA, while only 197 started new or increased their positions in HCA.

2. Hedge funds still collectively hold 262.04 million shares of HCA.

3. HCA will report its next quarterly earnings Jan. 30. Analysts expect earnings of $1.87 per share, which is down 1.06 percent from last year's $1.89 per share.

4. Despite the hedge fund reductions, 72 percent of market analysts are generally positive concerning HCA. Out of 29 analysts, 21 awarded HCA a buy rating, while seven issued a hold rating.

5. Analysts have issued targets between $74 and $105 per share. The consensus is at $89.66 per share.

More articles on transactions/valuations:
10 statistics on ASC shareholder equity
EmCare pays $33M to resolve alleged illegal remuneration & more — 6 ASC company key notes
Medical Facilities Corp. to pay $0.09 dividend — 4 insights

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months